Kaman (NYSE:KAMN) Rating Lowered to Hold at StockNews.com | MarketBeat

2022-07-09 12:40:46 By : Mr. Benjamin Tang

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

Kaman (NYSE:KAMN - Get Rating) was downgraded by StockNews.com from a "buy" rating to a "hold" rating in a research note issued to investors on Tuesday.

A number of other analysts have also recently weighed in on KAMN. CJS Securities initiated coverage on shares of Kaman in a research report on Tuesday, June 14th. They set a "market outperform" rating and a $45.00 price target for the company. KeyCorp cut their target price on shares of Kaman from $52.00 to $45.00 in a research note on Wednesday, May 4th.

Shares of NYSE:KAMN opened at $31.60 on Tuesday. The company has a quick ratio of 2.93, a current ratio of 4.80 and a debt-to-equity ratio of 0.25. The company has a market cap of $884.10 million, a P/E ratio of 22.25 and a beta of 1.25. Kaman has a 52 week low of $30.19 and a 52 week high of $51.17. The company has a 50-day moving average price of $34.96 and a 200 day moving average price of $39.82.

Kaman (NYSE:KAMN - Get Rating) last issued its quarterly earnings data on Monday, May 2nd. The industrial products company reported $0.15 earnings per share for the quarter, missing analysts' consensus estimates of $0.26 by ($0.11). The business had revenue of $158.05 million for the quarter, compared to analysts' expectations of $178.00 million. Kaman had a return on equity of 6.37% and a net margin of 5.71%. During the same period last year, the business earned $0.29 earnings per share. Analysts expect that Kaman will post 1.82 EPS for the current year.

If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult. And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!

In related news, Director E Reeves Callaway III sold 3,707 shares of the firm's stock in a transaction that occurred on Tuesday, June 14th. The shares were sold at an average price of $34.92, for a total transaction of $129,448.44. Following the completion of the sale, the director now directly owns 2,712 shares in the company, valued at $94,703.04. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Company insiders own 0.77% of the company's stock.

A number of institutional investors have recently bought and sold shares of the stock. Wall Street Access Asset Management LLC acquired a new position in Kaman in the 1st quarter worth approximately $219,000. Advisors Asset Management Inc. lifted its position in Kaman by 32.8% in the 1st quarter. Advisors Asset Management Inc. now owns 15,121 shares of the industrial products company's stock worth $657,000 after buying an additional 3,731 shares in the last quarter. Royal Bank of Canada lifted its position in Kaman by 86.0% in the 1st quarter. Royal Bank of Canada now owns 2,197 shares of the industrial products company's stock worth $96,000 after buying an additional 1,016 shares in the last quarter. Captrust Financial Advisors lifted its position in Kaman by 21.9% in the 1st quarter. Captrust Financial Advisors now owns 4,582 shares of the industrial products company's stock worth $200,000 after buying an additional 822 shares in the last quarter. Finally, State Street Corp lifted its position in Kaman by 13.5% in the 1st quarter. State Street Corp now owns 1,458,842 shares of the industrial products company's stock worth $63,716,000 after buying an additional 173,595 shares in the last quarter. 88.29% of the stock is owned by hedge funds and other institutional investors.

Kaman Corporation, together with its subsidiaries, operates in the aerospace, defense, medical, and industrial markets. The company operates through three segments: Engineered Products, Precision Products, and Structures. The Engineered Products segment produces and markets aircraft bearings and components; super precision miniature ball bearings; and spring energized seals, springs, and contacts.

Featured StoriesGet a free copy of the StockNews.com research report on Kaman (KAMN)Using MarketBeat Market Data Tools To Find Strong Stocks in a Bear MarketSchnitzer Steel Witnesses A Strong Quarter On The Back Of Strong Domestic DemandMarketBeat: Week in Review 6/27 – 7/1Accolade Moves Higher But Growth Is Slowing ZIM Integrated Shipping Services (ZIM): Don't Miss This Dividend

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Before you consider Kaman, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kaman wasn't on the list.

While Kaman currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

Complete the form below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter:

Today’s interview is a little different, in that you get a LOT of market perspective from someone who’s been analyzing stocks from the ground up, for more than three decades. In this conversation, Kate chats with Nancy Zambell, the chief analyst for the Cabot Money Club Letter - and Nancy has a really deep and varied background in the financial industry - as she mentions in this interview, she’s been a banker, real estate professional, and a stock market analyst.

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

Twitter Facebook StockTwits Financial Juice YouTube

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved. 326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at contact@marketbeat.com | (844) 978-6257 MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.